[1]BioorganicandMedicinalChemistryLetters,2016,vol.26,p.5819-5824
[2]Patent:WO2018/13508,2018,A1.Locationinpatent:Paragraph0126
26510-52-1
75418-74-5
150401-96-0
338760-66-0
90922-53-5
123440-85-7
127666-86-8 | lithium(1+) ion 3-bromopropane-1-sulfonate | AA01DTC5 | MFCD31558964
1780843-50-6 | 2-amino-8-bromoquinazoline-4-carboxylic acid | AA01DTJ2 | MFCD31414467
1065094-15-6 | 3-Quinolinecarboxylic acid, 5-bromo-8-fluoro-4-hydroxy-, ethyl ester | AA01DTOP | MFCD28010429
54705-41-8 | (R)-5-Phenyloxazolidin-2-one | AA01DU0Y | MFCD24549785
1820787-94-7 | IRAK4-IN-1 | AA01DU7J | MFCD31620830
1006434-30-5 | 1-[1-Methyl-3-(trifluoromethyl)-1h-pyrazol-5-yl]ethanone | AA01DUTP | MFCD04968850
1159814-77-3 | 2-AMINO-6-(4-PYRIDYL)PYRAZINE | AA01DUXK | MFCD12033436
1248550-93-7 | 5-ACETAMIDO-2-METHYLPYRIDINE-3-CARBOXYLIC ACID | AA01DV0V | MFCD17267672
128600-49-7 | 1-(1H-pyrrol-3-yl)propan-2-amine | AA01DV49 | MFCD19206905
1341518-87-3 | 2,2,2-trifluoro-1-(pyrazin-2-yl)ethanol | AA01DV7X | MFCD19622683